IEEE Style Citation: Nikhil Bhardwaj, Shubham Jaiswal, Ananya Singh, S.B Nikam, “Detection and Recovery of Economic Losses in Sales Person Based Pharmaceutical Bussiness,” International Journal of Computer Sciences and Engineering, Vol.7, Issue.6, pp.188-190, 2019.
MLA Style Citation: Nikhil Bhardwaj, Shubham Jaiswal, Ananya Singh, S.B Nikam "Detection and Recovery of Economic Losses in Sales Person Based Pharmaceutical Bussiness." International Journal of Computer Sciences and Engineering 7.6 (2019): 188-190.
APA Style Citation: Nikhil Bhardwaj, Shubham Jaiswal, Ananya Singh, S.B Nikam, (2019). Detection and Recovery of Economic Losses in Sales Person Based Pharmaceutical Bussiness. International Journal of Computer Sciences and Engineering, 7(6), 188-190.
BibTex Style Citation:
@article{Bhardwaj_2019,
author = {Nikhil Bhardwaj, Shubham Jaiswal, Ananya Singh, S.B Nikam},
title = {Detection and Recovery of Economic Losses in Sales Person Based Pharmaceutical Bussiness},
journal = {International Journal of Computer Sciences and Engineering},
issue_date = {6 2019},
volume = {7},
Issue = {6},
month = {6},
year = {2019},
issn = {2347-2693},
pages = {188-190},
url = {https://www.ijcseonline.org/full_paper_view.php?paper_id=4529},
doi = {https://doi.org/10.26438/ijcse/v7i6.188190}
publisher = {IJCSE, Indore, INDIA},
}
RIS Style Citation:
TY - JOUR
DO = {https://doi.org/10.26438/ijcse/v7i6.188190}
UR - https://www.ijcseonline.org/full_paper_view.php?paper_id=4529
TI - Detection and Recovery of Economic Losses in Sales Person Based Pharmaceutical Bussiness
T2 - International Journal of Computer Sciences and Engineering
AU - Nikhil Bhardwaj, Shubham Jaiswal, Ananya Singh, S.B Nikam
PY - 2019
DA - 2019/06/30
PB - IJCSE, Indore, INDIA
SP - 188-190
IS - 6
VL - 7
SN - 2347-2693
ER -
VIEWS
PDF
XML
375
351 downloads
218 downloads
Abstract
It will explore the current supply chain trend which is in the pharmaceutical industry. It’s important objective was to characterize the pharmaceutical industry and it will identify the proper supply chain practice. As we know that The pharmaceutical industry will not be renowned for its supply chain management abilities but on the other hand many other high publicized industries they do have profitably exploit their proper supply chain. It is a interesting topic for particular research. Let’s take a look . we are going to argue that an excellent supply chain is paramount to the pharmaceutical industry boom. This particular business objective of the pharma industry including there was a need so that to be ensure that we have the drugs are protected from adulteration and counterfeiting, remove and it will destroy in the safe and environmental friendly manner. We see that Clearly and they are not at all commonly use metrics so that it assess the major performance of a particular company or a particular supply chain.
[1]. Abbott Laboratories. 1994-2004. 10-K Forms for Securities and Exchange Commission. http://www.secinfo.com/dRqWm.45Sx.htm, accessed March, 2010.
[2]. AstraZeneca International. 1999-2004. Annual Reports. http://www.astrazeneca.com/investors/annual-reports/, accessed April, 2010.
[3]. Bausch & Lomb Inc. 1994-2004. 10-K Forms for Securities and Exchange Commission. http://www.secinfo.com/$/SEC/Documents.asp?CIK=10427&Party=BFO&Type=10K&Label=Annual+Reports+%2D%2D+Form+10%2DK, accessed March, 2010.
[4]. Bowe, Christopher, and Demetri Sevastopulo. 2004. “Senators unite on bill for cheaper medicines.” Financial Times (UK edition). April 22: p. 8
[5]. Bowe, Christopher. 2004b. “States warm to reimport of drugs in US.” Financial Times (UK edition). August 23: p. 6
[6].Bristol-Myers Squibb Co. 1994-2004. 10-K Forms for Securities and Exchange Commission. http://www.secinfo.com/$/SEC/Documents.asp?CIK=14272&Party=BFO&Type=10K&Label=Annual+Reports+%2D%2D+Form+10%2DK, accessed March, 2010.
[7]. Chiron Corp. 1995-2004. 10-K Forms for Securities and Exchange Commission. http://www.secinfo.com/$/SEC/Documents.asp?CIK=706539&Party=BFO&Type=10K&Label=Annual+Reports+%2D%2D+Form+10%2DK, accessed March, 2010.
[8]. Cytogen Corp. 1995-2004. 10-K Forms for Securities and Exchange Commission. http://www.secinfo.com/$/SEC/Documents.asp?CIK=725058&Party=BFO&Type=10K&Label=Annual+Reports+%2D%2D+Form+10%2DK, accessed March, 2
VIEWS
PDF 
XML 
